Psychology & Intimacy GLP-1 Receptor Agonists Show Promising Mental Health Benefits in Large-Scale Study May 19, 2026 Rebecca Shoemaker A groundbreaking study involving nearly 100,000 individuals has revealed that medications commonly prescribed for type 2 diabetes and obesity, such as Ozempic and Wegovy, may offer significant and unexpected benefits…
Sex Education & Pedagogics 2015 SKYN® Sex Survey Show Millennials Sex Habits May 18, 2026 Gabriella Anastasia The Evolution of Sexual Wellness and the Orgasm Gap One of the most striking revelations from the 2015 SKYN survey is the apparent narrowing of the "orgasm gap," a term…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study May 10, 2026 Rebecca Shoemaker New research indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs widely used for managing type 2 diabetes and obesity, may also offer significant benefits for mental well-being.…
Psychology & Intimacy Blood Tests Tracking White Blood Cell Aging Show Promise for Identifying Depression Through Emotional and Cognitive Symptoms May 5, 2026 Rebecca Shoemaker New research offers a potential biological marker for depression, shifting focus from physical ailments to the nuanced emotional and cognitive impacts of the condition. This advancement could pave the way…
Sex Education & Pedagogics 2015 SKYN® Sex Survey Show Millennials Sex Habits May 3, 2026 Gabriella Anastasia Closing the Orgasm Gap and Normalizing Sexual Aids One of the most striking revelations of the 2015 survey is the apparent narrowing of the "orgasm gap," a term often used…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health, Reducing Psychiatric Hospitalizations and Work Absences April 28, 2026 Rebecca Shoemaker New, large-scale research involving nearly 100,000 individuals has unveiled a significant correlation between the use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic, Wegovy, and Rybelsus),…
Psychology & Intimacy GLP-1 Medications Show Significant Promise in Improving Mental Health Outcomes April 20, 2026 Rebecca Shoemaker New, large-scale research conducted by an international consortium of scientists has revealed a compelling link between the use of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, commonly prescribed for type 2 diabetes…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study April 13, 2026 Rebecca Shoemaker New research spearheaded by an international consortium of scientists is shedding light on a potential, and perhaps unexpected, benefit of GLP-1 receptor agonists, a class of medications widely recognized for…
Psychology & Intimacy Psilocybin Derivatives Show Promise for Psychedelic-Inspired Therapies with Reduced Hallucinations April 11, 2026 Rebecca Shoemaker Psilocybin, the naturally occurring psychoactive compound in "magic mushrooms," has emerged as a significant area of scientific inquiry, holding considerable therapeutic potential for a spectrum of mental health and neurological…
Psychology & Intimacy GLP-1 Medications Show Remarkable Links to Improved Mental Health Outcomes, New Large-Scale Study Reveals April 6, 2026 Rebecca Shoemaker Groundbreaking research conducted by an international consortium of scientists from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia has unveiled a significant association between…
